
Landmark BGH Decision on Fampridine-SR: New Standards for Novelty and “Reasonable Expectation of Success” in Pharma Patents
The German Federal Court of Justice (BGH) has recently overturned a lower court decision, confirming the validity of a patent for Fampridine-SR used to increase
